| 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 药品经营(元) | 65,633,572,737.07 | 33,123,263,160.85 | 57,109,719,091.58 | 28,095,897,814.34 |
| 医疗器械类(元) | 12,478,521,647.00 | 6,666,976,452.74 | 9,513,641,003.02 | 4,024,441,529.24 |
| 其他主营业务(元) | - | - | - | 554,642,781.50 |
| 其他(元) | 2,007,012,961.00 | 924,796,422.05 | 1,205,650,343.53 | 554,642,781.50 |
| 营业成本(元) | ||||
| 药品经营(元) | 61,196,196,470.76 | 30,638,864,954.94 | 52,733,845,867.34 | 25,960,637,946.51 |
| 医疗器械类(元) | 10,850,127,706.11 | 5,860,420,837.24 | 8,355,319,170.47 | 3,603,345,955.35 |
| 其他主营业务(元) | - | - | - | 344,746,089.31 |
| 其他(元) | 1,764,068,382.24 | 799,728,976.82 | 919,614,716.49 | 344,746,089.31 |
| 毛利(元) | ||||
| 药品经营(元) | 4,437,376,266.31 | 2,484,398,205.91 | 4,375,873,224.24 | 2,135,259,867.83 |
| 医疗器械类(元) | 1,628,393,940.89 | 806,555,615.50 | 1,158,321,832.55 | 421,095,573.89 |
| 其他主营业务(元) | - | - | - | 209,896,692.19 |
| 其他(元) | 242,944,578.76 | 125,067,445.23 | 286,035,627.04 | 209,896,692.19 |
| 毛利率(%) | ||||
| 药品经营(%) | 6.76 | 7.50 | 7.66 | 7.60 |
| 医疗器械类(%) | 13.05 | 12.10 | 12.18 | 10.46 |
| 其他主营业务(%) | - | - | - | 37.84 |
| 其他(%) | 12.10 | 13.52 | 23.72 | 37.84 |
| 收入构成(%) | ||||
| 药品经营(%) | 81.92 | 81.35 | 84.20 | 84.55 |
| 医疗器械类(%) | 15.57 | 16.37 | 14.03 | 12.11 |
| 其他主营业务(%) | - | - | - | 1.67 |
| 其他(%) | 2.51 | 2.27 | 1.78 | 1.67 |
| 毛利构成(%) | ||||
| 药品经营(%) | 70.34 | 72.73 | 75.18 | 71.75 |
| 医疗器械类(%) | 25.81 | 23.61 | 19.90 | 14.15 |
| 其他主营业务(%) | - | - | - | 7.05 |
| 其他(%) | 3.85 | 3.66 | 4.91 | 7.05 |